CUPE NL is encouraged by news of the imminent arrival of the Pfizer COVID-19 vaccine and the news that health care workers, particularly those in long term care or positions with potential for exposure to COVID-19. This is an important development for the health and safety of our members across the province.
Our members providing front line health services have been working under the most difficult conditions as they strive to provide quality care to those in need and they deserve safe working conditions.
CUPE NL encourages all of our members to avail themselves of the vaccine(s) when it is made available to them as COVID-19 will remain a threat to the health and safety of our workplaces for the foreseeable future.
While this vaccine was developed quickly compared to others, its success is due to the diligent work of countless researchers and health professions. CUPE has been monitoring published literature and regulatory processes and is confident in Health Canada’s assessment and approval process for vaccines.
Members who are interested in more information on how vaccines are developed and approved for use in Canada can find more here: canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/development-approval-infographic.html